INTRODUCTION
B cells are central in several autoimmune diseases characterized by specific pathogenic autoantibodies, such as immune thrombocytopenia and autoimmune hemolytic anemia (1) (2) (3) .
In systemic autoimmune chronic inflammatory diseases, the role of B cells is much more complex, and several mechanisms of action have been hypothesized to explain how B-cell depletion can play a therapeutic role. In fact, B-cell depletion has become a remarkable tool to elucidate the pathogenetic role of B cells in such illnesses (4) . In rheumatoid arthritis (RA), several studies have characterized the status of B cells and of their subsets in peripheral blood (PB), as well as in the bone marrow before and after B-cell depletion (5-7). A general consensus was reached that no real differences exist in the PB between RA patients and healthy controls at baseline (8) . After B-cell depletion, the cells that have been shown to reappear first in PB are CD38 seem to be the subset increased by the time of B-cell recovery (9, 10) . In contrast to the nearly complete depletion and further regeneration of B cells in the PB after rituximab treatment, the B-cell depletion in other sites such as lymph nodes or tertiary lymphoid tissues appears to be directly related to the response to B-cell depletion (11, 12) . Failure to deplete B cells in these tissues may lead to nonresponse or early relapse, probably associated with a partial or ineffective reduction in infiltrating plasmablasts or CD138 + plasma cells in these tissues. In fact, as suggested by Thurlings et al. (12) , the reduction in synovial plasma cells at 16 weeks correlated with the reduction in serum autoantibodies and predicted clinical response at 24 weeks (12) . Thus, the general conclusion has been drawn that CD27 memory B cells and plasma cells are the most important play- Alessandro Michelutti, 1 Elisa Gremese, 1 Francesca Morassi, 2 Luca Petricca, 1 Vincenzo Arena, 2 Barbara Tolusso, 1 Stefano Alivernini, 1 Giusy Peluso, 1 Silvia Laura Bosello, 1 and Gianfranco Ferraccioli 
MATERIALS AND METHODS

Patients and Control Populations
PB, synovial fluid (SF) or synovial tissue (ST) were collected from 27 consecutive patients fulfilling the ACR 1987 revised criteria for RA (14) (18 women, mean age 54.7 ± 19.7 years) and 13 patients with knee synovitis (no-RA: 9 women, mean age 49.0 ± 15.3 years). Clinical and laboratory evaluations were performed before the synovial biopsy. None of the patients had received corticosteroids in the last 4 wks or biologics in the last 3 months. The analysis included the number of tender and swollen joints, erythrocyte sedimentation rate, C-reactive protein, Disease Activity Score and Health Assessment Questionnaire score. Anti-CCP antibodies were tested using the secondgeneration commercial assay (a-CCP2; Axis-Shield Diagnostics, Dundee, UK) kit by an enzyme-linked immunosorbent assay (ELISA), with positive anti-CCP defined as >5 units/mL. The RF isotypes for IgA and IgM were measured by ELISA, using commercially available test systems (Orgentec Diagnostika, Mainz, Germany) and considered positive above a cutoff value of 20 units/mL. Characteristics of patient populations are shown in Table 1 .
All the patients were informed of the objective of the study and gave their consent Cytokine Testing All samples were tested for interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor (TNF)-α and monocyte chemotactic protein (MCP)-1. Cytokines were measured using a bead-based plex assay (Bender MedSystems, Vienna, Austria). The analytes bound to the antibodies linked to the fluorescent beads and then a biotin-conjugated second antibody mixture was added, followed by streptavidin-phycoerythrin, which permitted the emission of fluorescent signals. After incubation, samples were read with the flow cytometer (Navios; Beckman Coulter, Marseille, France). For calculation of the results, BMS FlowCytomix Pro software was used. Quantitative levels of cytokines were determined by comparison to standard curves, and they were reported as pg/mL. The detection limit of the assay was 4.2 pg/mL for IL-1β, 1.2 pg/mL for IL-6, 0.5 pg/mL for IL-8, 3.2 pg/mL for TNF-α and 18.2 pg/mL for MCP-1.
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Synovial Biopsies
All patients underwent ultrasoundguided synovial biopsy of an actively inflamed joint (knee), performed under local anesthesia using a 14-G needle (Precisa 1410, HS Hospital Service Spa, Latina, Italy), to obtain at least six samples from different sites in the joint during each procedure.
Specimens from synovial biopsy were fixed with phosphate-buffered formalin, embedded in paraffin, sectioned at 3-4 μm and stained with hematoxylin and eosin or used for immunohistochemical analysis. All tissue samples were reviewed by two pathologists (F Morassi and V Arena) who were unaware of any clinical, serological or immunohistological findings (15) .
Hematoxylin and eosin sections of tissue samples were analyzed for the organizational structure of the inflammatory infiltrate with attention to the topographical arrangement of T cells, B cells and macro phages to define the histological pattern of synovitis as either diffuse or aggregate. An aggregate pattern was defined as the presence of inflammatory cells with a 20-cell diameter focus at least, if less, the pattern was considered as diffuse (16, 17) . The definition of aggregates includes both the aggregate and germinal center (GC)-like infiltrates (defined by the presence of follicular dendritic cells), since one of the aims of the study was to assess the degree of differentiation toward GC reactions to evaluate if the aggregate infiltrates have a biological or clinical relevance. The specific pattern was evaluated in two different tissue sections 50 μm apart to further minimize sampling error (Supplemental Table 1 ).
For immunohistochemistry (IHC) analysis, tissue sections were deparaffinized (19, 20) . As shown in the plots, naive B cells accumulate preferentially in the PB, whereas memory subsets localize in the synovial compartment. The distribution of B-cell subsets was similar in seropositive as well as in seronegative RA patients and in the RA cohort compared with no-RA cohort, both in blood and in the synovial compartments. *P < 0.05, SF versus PB.
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RESULTS
Demographic, Immunological and Clinical Data of Patients
RA patients were categorized into two subgroups (AB + or AB -) on the basis of the presence or absence of autoantibodies. There were no differences in the sex profile, age and inflammatory parameters between RA and no-RA patients. Swollen joint count (SJC) was higher in the RA group than in the no-RA group (11.3 ± 10.2 versus 1.7 ± 1.1, P = 0.01). As shown in Table 1 , positivity for autoantibodies (anti-CCP and/or RF-IgA and/or RF-IgM) was present in 14 (51.9%) of 27 RA patients and in 1 (RF-IgM positivity) of the 13 no-RA patients (7.7%, P = 0.01 versus RA patients).
PB and SF Mononuclear Cell Distribution in RA and No-RA Patients
No significant differences were found in WBC count and lymphocyte percentage between AB + and AB -RA patients and between AB + and/or AB -RA and no-RA patients in PB or SF (Table 2 ). In PB, B-cell percentage was similar in all the groups, whereas we found a higher percentage of B cells in SF of AB + RA patients (2.2 ± 3.0%) compared with no-RA patients (0.6 ± 0.8%, P = 0.02) ( Table 2) .
Both in AB + and AB -RA patients and in no-RA patients, the percentage of lymphocytes and CD19 + cells were higher in PB than in SF, whereas we found no differences in WBC count (Table 2) .
PB and SF B-Cell Subset Distributions in RA and No-RA Patients
We performed a multicolor flowcytometric analysis of PB mononuclear cells isolated from SF and paired PB samples of RA (AB + and AB -) and no-RA patients, considering the expression of IgD, CD38 and CD27 as cell surface markers (Bm1-Bm5 or IgD-CD27 classifications) (19, 20) as well as the expression of ZAP70 on B cells (16) . Considering the Bm1-Bm5 classification, we found no differences in B-cell subset distribution between RA (AB + or AB -)
and no-RA both in PB and SF (Table 2) . Moreover, the percentage of B cells expressing ZAP70 was similar in RA subgroups and no-RA patients both in PB and SF (Table 2) . Both in AB + and AB -RA patients, the percentage of Bm2+Bm2′ was significantly lower in the SF than in the PB, with a significantly higher percentage of Bm5 (%) in SF than in PB. The obvious result of such a difference in compart- mentalization is the significantly lower ratio of Bm2+Bm2′/eBm5+Bm5 in SF compared with PB (P < 0.05; Figure 1) .
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In no-RA patients as well, we found that, in SF, the percentage of Bm2+Bm2′ was lower and the percentage of Bm5 was higher than in PB (Bm2+Bm2′: P = 0.03; Bm5: P = 0.03), data confirmed by the lower ratio of Bm2+Bm2′/ eBm5+Bm5 in SF compared to PB [P = 0.03]). As shown in RA patients, also in no-RA patients, the percentage of CD19 + /ZAP70 + was higher in SF than in PB (P < 0.01) ( Table 2 and Figure 1) . Data of B-cell subset distribution with the Bm1-Bm5 classification was con- 
Immunohistochemistry in Synovial Biopsies of RA and No-RA Patients
Synovial samples from RA and no-RA patients were characterized by mononuclear cell infiltrates and consisted mainly of lymphocyte-and macrophage like cells and plasma cells. In addition, the IHC phenotype analysis showed similar counts in AB + and AB -RA patients (P = 0.84). In our samples, synovial lining layer proliferation and fibrinoid necrosis were also observed. For RA, 14 (51.9%) specimens revealed diffuse lymphocyte infiltration, and they were categorized as diffuse rheumatoid synovitis. Lymphocyte aggregates, sometimes with germinal center-like structures, were observed in 13 (48.1%) samples. Such RA synovial samples were therefore classified as an aggregate pattern of synovitis. Four of 13 no-RA synovial samples showed aggregate pattern of synovitis (30.8%, P = 0.33 versus RA patients).
We found no significant differences in the analysis of CD68 Figure 3 . Mean cytokine levels in PB and SF of RA patients. The plasma and SF levels of MCP-1, IL-8, IL-1β, TNF-α and IL-6 in RA (AB + and AB -) and no-RA patients were assessed using a bead-based assay kit.
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Demographic Characteristics, Inflammatory Milieu and B-Cell Phenotypes in RA Patients with an Aggregate or Diffuse Pattern of Synovitis
In RA, patients with an aggregate pattern had a longer disease duration than patients with diffuse synovitis (P = 0.05) ( Table 3) . Regarding the B-cell distribution subsets, in patients with aggregate synovitis, the percentage of Bm2+Bm2′ was lower in PB and in SF compared with patients with diffuse phenotype (PB: P = 0.02; SF: P = 0.01). These data were confirmed by the lower percentage of IgD +
CD27
-B cells in SF of aggregate synovitis compared with diffuse synovitis. However, the percentage of SF Bm5 was significantly higher in aggregate synovitis (P = 0.05), and we found a lower SF Bm2+Bm2′/eBm5+Bm5 ratio in aggregate compared with diffuse phenotype (0.02 ± 0.01 versus 0.1 ± 0.1, respectively; P = 0.01) ( Table 3 and Figure  4A -F). As already reported (13), the percentage of CD19 + /ZAP70 + cells was higher in SF than in PB in RA patients with both a diffuse and aggregate pattern of synovitis ( Figure 4G ). The IHC analysis revealed that the aggregate pattern was associated with a higher CD3 count in synovial tissue compared with the diffuse phenotype (P = 0.02); the presence of CD27 positivity alone, which marks either T cells as well as B memory cells, was also statistically increased in aggregate versus diffuse type (P = 0.01) ( Table 3) .
DISCUSSION
This study aimed to investigate the distribution of B-cell subsets in blood and synovial fluids and tissues of seropositive and seronegative RA patients because it is of fundamental importance to understand how B cells behave during rheumatoid inflammation and how B-cell depletion could work in this disease. Our data show that naive B cells accumulate in the PB, and the maturememory subsets localize in the synovial compartment. Moreover, we found a similar distribution of the B-cell subsets in seropositive as well as in seronegative RA patients and in the RA compared to no-RA cohorts, both in blood and in the synovial compartments. We also observed a gradient of B-cell maturation between the PB and the SF, thus suggesting that a persistent inflammation probably leads to a maturation of B cells in the joint. In particular, we observed that Bm5 cells are more abundant in the synovial compartment than in the PB. These data were confirmed by the analysis of IgD/CD27. (24, 25) . Recent data have provided evidence that the synovial fluid of RA patients is enriched of memory B cells that express CXCR4 together with IL-8 receptors CXCR1 and CXCR2, and these cells may be recruited into the synovial membrane, where they accumulate and are responsible for the follicularlike structure formation, thus contributing to the perpetuation of chronic synovitis (22) . Our study supports these observations, as we found that the levels of IL-8 and MCP-1, cytokines with proinflammatory and chemotactic functions, were significantly higher in PB of RA compared with no-RA (13) . Consistent with these data, van de Sande et al. (26) recently suggested that the presence of lymphocyte aggregates seems to be related to the level of synovial inflammation in early-arthritis patients and can change over time.
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In conclusion, we provide data showing that a subset of memory B cells characterized by CD27 + /IgD -/ZAP70 + accumulate preferentially in the joints of RA patients and that there seems to be a dynamic maturation of B cells according to disease activity and disease duration. Also, no difference exists between RA AB + and RA AB -and that seropositive and seronegative differ more in terms of degree of local inflammation than in terms of subsets of B-cell involvement.
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